Cbay stock forecast.

Stock Price Forecast. According to 11 stock analysts, the average 12-month stock price forecast for CBAY stock stock is $22.64, which predicts an …EBAY Regular Dividend: EBAY will begin trading ex-dividend today with a $0.25 dividend payable to shareholders of record as of 12/01/23. Quote. Profile. News. Charts. Forecasts. Financials ...Stem, Inc. (NYSE:STEM) released its earnings results on Thursday, November, 2nd. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.01. The firm had revenue of $133.74 million for the quarter, compared to the consensus estimate of $182.46 million.Nov 24, 2023 · A high-level overview of CymaBay Therapeutics, Inc. (CBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Cymabay Therapeutics (CBAY) Company Description. CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral ...

CymaBay Therapeutics Inc. (CBAY) Reports Q3 Loss, Misses Revenue Estimates. by Zacks Equity Research Published on November 10,2021. CymaBay Therapeutics Inc. (CBAY) delivered earnings and revenue ...

September 8, 2023 at 1:12 PM · 3 min read. Shares of clinical-stage biopharmaceutical company CymaBay Therapeutics, Inc. CBAY gained after it announced positive top-line results from its late ...What are analysts’ forecasts for CBAY stock? Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CBAY stock returns are also predicted based on historical data. According to our research, CBAY stock is a bad long-term investment.Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...Track Cymabay Therapeutics Inc (CBAY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. Join the Conversation! Build your trading network; Follow your favorite assets ...

Last month, Menold Daniel, the VP Finance of CBAY bought 15,500.00 shares for a total of $79,010.00. TipRanks has tracked 36,000 company insiders and found that a few of them are better than ...

See the latest CymaBay Therapeutics Inc stock price (CBAY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Dec 1, 2023 · The consensus price target of analysts on Wall Street is $24.42, which implies an increase of 21.66% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.00 and $34.00 respectively. As a result, CBAY is trading at a discount of -77.73% off the target high and -4.55% off the low. AFIB Stock 12 Months Forecast. $1.62. (184.26% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Acutus Medical in the last 3 months. The average price target is $1.62 with a high forecast of $2.50 and a low forecast of $0.74. The average price target represents a 184.26% change from the last price of $0.57.Cymabay Therapeutics Inc Stock Price Forecast, "CBAY" Predictons for2025CBAY Stock 12 Months Forecast. $24.40. (29.93% Upside) Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. …Average target price for CBAY - CymaBay Therapeutics is predicted at $2.2462 within next 1 yearCBAY Stock 12 Months Forecast. $24.40. (29.93% Upside) Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. …

CBM Bancorp, Inc. (CBMB) share price prediction for 2023, 2024, 2025, 2026 and 2027. CBMB one year forecast. CBM Bancorp stock monthly and weekly forecasts.Nov 30, 2023 · According to 11 stock analysts, the average 12-month stock price forecast for CBAY stock stock is $20.18, which predicts an increase of 23.35%. The lowest target is $12 and the highest is $33. On average, analysts rate CBAY stock stock as a strong buy. CBAY Earnings Date and Information. CymaBay Therapeutics last announced its quarterly earnings results on November 7th, 2023. The biopharmaceutical company reported ($0.32) EPS for the quarter, missing …EBAY Regular Dividend: EBAY will begin trading ex-dividend today with a $0.25 dividend payable to shareholders of record as of 12/01/23. Quote. Profile. News. Charts. Forecasts. Financials ...Based on our forecasts, a long-term increase is expected, the "CBAY" stock price prognosis for 2028-10-27 is 18.476 USD. With a 5-year investment, the revenue is …All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.

Analysts Offer Insights on Healthcare Companies: CymaBay Therapeutics (CBAY), Mersana Therapeutics (MRSN) and Verona Pharma (VRNA) November 8, 2023 TipRanks.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0280 between high and low, or 8.46%.For the last week the stock has had daily average volatility of 7.18%.. Our recommended stop-loss: $0.325 (-3.60%) (This stock …Nov 3, 2023 · Cymabay Therapeutics Inc (NASDAQ:CBAY) trade information. Cymabay Therapeutics Inc (CBAY) has traded red over the past five days. The stock hit a weekly high of 16.87 this Thursday, 11/02/23. The 5-day price performance for the stock is 8.04%, and 17.06% over 30 days. With these gigs, the year-to-date price performance is 161.56%. Nov 24, 2023 · A high-level overview of CymaBay Therapeutics, Inc. (CBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Jun 30, 2023 · What happened. Shares of CymaBay Therapeutics ( CBAY 4.87%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ... He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ...Based on analysts offering 12 month price targets for CBAY in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .CPG Stock 12 Months Forecast. Based on 10 Wall Street analysts offering 12 month price targets for Crescent Point Energy in the last 3 months. The average price target is C$14.80 with a high forecast of C$19.00 and a low forecast of C$13.00. The average price target represents a 53.50% change from the last price of C$9.64.Investors often compare top stocks against the Russell 3000 Index, a broad measure of the U.S. stock market comprising 3,000 large publicly traded companies or 96% of the investable U.S. equity ...

What happened. A significant miss on quarterly earnings combined with a big change in its C-suite put a damper on CymaBay Therapeutics (CBAY 3.03%) stock this week. According to data compiled by S ...

CBAY 8.19%. 70. See CBAY Report. CymaBay Therapeutics Inc ( CBAY) is near the top in its industry group according to InvestorsObserver. CBAY gets an overall rating of 80. That means it scores higher than 80 percent of stocks. CymaBay Therapeutics Inc gets a 91 rank in the Biotechnology industry. Biotechnology is number 13 out of 148 …

About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.Over the past 3 months, 14 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts are typically employed by large Wall Street banks and tasked with ...The consensus price target of analysts on Wall Street is $24.42, which implies an increase of 21.66% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.00 and $34.00 respectively. As a result, CBAY is trading at a discount of -77.73% off the target high and -4.55% off the low.Village Farms International Inc () Stock Market info Recommendations: Buy or sell Village Farms International stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Village Farms International share forecasts, stock quote and buy / sell signals below.According to present data Village Farms International's VFF shares and …See CymaBay Therapeutics, Inc. (CBAY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.The current CymaBay Therapeutics [ CBAY] share price is $17.90. The Score for CBAY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal. CBAY is currently trading in the 70-80% percentile range relative to its …5 brokers have issued 12-month price targets for X4 Pharmaceuticals' stock. Their XFOR share price targets range from $3.00 to $5.00. On average, they anticipate the company's share price to reach $3.50 in the next year. This suggests a possible upside of 359.6% from the stock's current price.What happened. Shares of CymaBay Therapeutics ( CBAY -1.16%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ...

Is Cymabay Therapeutics (NASDAQ:CBAY) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, ...CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta for the treatments of autoimmune liver disease, primary ...Dec 1, 2023 · CBAY Earnings Date and Information. CymaBay Therapeutics last posted its earnings results on November 7th, 2023. The biopharmaceutical company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.02. Aug 2, 2022 · Against this backdrop, Wall Street believes CBAY's long-term growth narrative is strong and that its $3.26 share price reflects the ideal entry point. ... (See ABSI stock forecast on TipRanks) Instagram:https://instagram. affordable stocks to buy nowinfinite energy stockhow to find stocks for day tradingbest china etf cbay stock forecast cnn. CBAY stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Stock news by MarketWatch. … Monday, November 7, 2022 Edit. learn manga ... November 07, 2022 Edit. forecast oracle price wallpaper. oracle stock price forecast 2023. See Oracle Corporation stock price …Latest CBAY News | Press Releases See All CBAY News Today’s Trading Data as of 3:59pm ET, 11/20/2023 Growth & Valuation Competitors Data as of 4:00pm ET, 11/20/2023 Financials Profile... view stock pricesvacasa news CBAY stock has been performing well according to 12 analysts offering 12-month price forecasts. The median target price is $22.50, with a high estimate of $33.00 and a low estimate of $19.00. This indicates a potential increase of 37.95% from the last recorded price of $16.31. The consensus among 13 polled investment analysts is to buy stock in ... robotics etfs According to . 9 Wall Street analysts that have issued a 1 year CBAY price target, the average CBAY price target is $24.56, with the highest CBAY stock price forecast at $34.00 and the lowest CBAY stock price forecast at $15.00. NextPlay Technologies, Inc. (NASDAQ:NXTP) announced its quarterly earnings results on Wednesday, January, 12th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The firm earned $4.20 million during the quarter, compared to the consensus estimate of $5.70 …